Kezar Life Sciences announces 1-for-10 reverse stock split

Kezar Life Sciences (KZR) announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of one-for-ten . The Reverse Stock Split will become effective at 5:00 p.m. Eastern Time on October 29. The Company’s common stock will begin trading on a post-split basis at the market open on October 30, 2024. The Reverse Stock Split is part of the Company’s plan to regain compliance with the minimum bid price requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits. The Reverse Stock Split was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders held on June 18 to be effected at the Board’s discretion within approved parameters. Following the Annual Meeting, the final ratio was approved by the Company’s Board on September 23 .